Patent ID: 8063062

Claim:
A compound of formula (1): or a tautomer, stereoisomer, N-oxide, or a pharmacologically acceptable salt of any of the foregoing, wherein: A is chosen from one of: wherein X is a sulfonyl or a carbonyl group, the sign + is the position at which one of (A 1a ) to (A 8 ) is connected to T of formula (1), each of R 1 , R 2 and R 3 is chosen from a hydrogen atom, a trifluoromethyl group, and a halogen atom, R 4 is chosen from a hydrogen atom, a halogen atom, a methyl group, an ethyl group, a trifluoromethyl group, a hydroxymethyl group, a fluoromethyl group, a 2,2,2-trifluoroethyl group, a propyl group, a methylsulfanyl group, a methylsulfinyl group, a methylsulfonyl group, an ethylsulfanyl group, an ethylsulfinyl group, an ethylsulfonvl group, a C 1-3 -dialkyl-aminomethyl group, a pyrrolidin-1-ylmethyl group, a piperidin-1-ylmethyl group, and a morpholin-4-ylmethyl group, and R is a hydrogen atom or a C 1-3 alkyl group; T is chosen from a saturated or unsaturated linear carbon chain having from 2 to 8 carbon atoms, wherein the carbon chain is optionally substituted with from 1 to 5 substituents chosen from a methyl group, an ethyl group, a hydroxy group, a fluoro atom, and an amino group, and wherein the carbon chain optionally comprises an additional nitrogen atom, optionally substituted with a C 1-3 alkyl group, or wherein the carbon chain optionally comprises an additional oxygen atom, sulphur atom, carbonyl group, sulfonyl group, amide group, sulfonamide group, ureido group, or aryl group, wherein the aryl group is optionally substituted with from 1 to 4 substituents chosen from a halogen atom, a cyano group, a methyl group, a methoxy group, a trifluoromethyl group, OCHF 2 , OCF 3 , SCF 3 , and a nitro group; B is chosen from one of: wherein the “+” symbol is the position at which one of (B1) to (B3) is connected to T of formula (1), R 5 is chosen from a hydrogen atom, a halogen atom, a methoxy group, and a trifluoromethoxy group, and m is 0, 1 or 2; and n is 0 or 1.